Pharmacogenomics of Thiazolidinediones

Trial Profile

Pharmacogenomics of Thiazolidinediones

Phase of Trial: Phase II

Latest Information Update: 15 Sep 2017

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms PPAR
  • Most Recent Events

    • 11 Sep 2017 Planned End Date changed from 1 May 2016 to 1 May 2018.
    • 11 Sep 2017 Planned primary completion date changed from 1 May 2016 to 1 May 2018.
    • 28 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top